Boehringer Ingelheim International GmbH
按来源企业名称核对申报品种与记录。
按来源记录的企业名称原文列出，未与关联企业合并。
以上计数仅限已载入受理记录；第一申请人记录与联合申请记录不相加。CDE 来源截至 2026/11/11 06:42。
申报品种
作为第一申请人的 440 件受理记录，按来源品种名称汇总为 50 个品种；来源截至 2026/11/11 06:42。
受理记录按受理号去重。品种仅按现有全半角与空白规则归一化，剂型、复方分别列示；申请类型沿用来源。展开每个品种查看逐件记录。已公开品种可进入品种页，其他品种不新增公开品种页。
BI3822971注射液 1 件 · 最近受理 2026/11/09
进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSL2600307 | 进口 | 2026/11/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
BI456906注射液 91 件 · 最近受理 2026/10/13
进口 · 65补充申请 · 26
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2600448 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600447 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600446 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600445 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600444 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600443 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600442 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2500145 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500144 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500143 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500142 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500141 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500140 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2500139 | 补充申请 | 2025/10/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400165 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400164 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400163 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400162 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400161 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400160 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400159 | 补充申请 | 2024/09/30 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2400197 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400196 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400195 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400194 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400193 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400192 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400191 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400190 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400189 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400188 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400187 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400186 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400185 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400184 | 进口 | 2024/08/07 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2400108 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400107 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400106 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400105 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400104 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400103 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2400102 | 补充申请 | 2024/06/14 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2400020 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400019 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400018 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400017 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400016 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400015 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400014 | 进口 | 2024/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300244 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300243 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300242 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300241 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300240 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300239 | 进口 | 2023/09/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300235 | 进口 | 2023/09/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300234 | 进口 | 2023/09/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300233 | 进口 | 2023/09/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300232 | 进口 | 2023/09/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300231 | 进口 | 2023/09/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300230 | 进口 | 2023/09/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300229 | 进口 | 2023/09/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300223 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300222 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300221 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300220 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300219 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300218 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300217 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300216 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300215 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300214 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300213 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300212 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300211 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300210 | 进口 | 2023/09/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2200142 | 补充申请 | 2022/09/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200141 | 补充申请 | 2022/09/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200140 | 补充申请 | 2022/09/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200139 | 补充申请 | 2022/09/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHB2200138 | 补充申请 | 2022/09/18 | Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc. | CDE ↗ |
| JXHL2101064 | 进口 | 2021/05/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101063 | 进口 | 2021/05/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101062 | 进口 | 2021/05/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101061 | 进口 | 2021/05/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101060 | 进口 | 2021/05/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2000360 | 进口 | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000359 | 进口 | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000358 | 进口 | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000357 | 进口 | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2000356 | 进口 | 2021/01/05 | Boehringer Ingelheim International GmbH | CDE ↗ |
BI3034701注射液 10 件 · 最近受理 2026/09/23
进口 · 10
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2600416 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600415 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600414 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600413 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600412 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600109 | 进口 | 2026/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600108 | 进口 | 2026/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600107 | 进口 | 2026/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600106 | 进口 | 2026/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600105 | 进口 | 2026/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
verducatib片 2 件 · 最近受理 2026/09/03
进口 · 2
乙磺酸尼达尼布软胶囊 14 件 · 最近受理 2026/08/12
进口再注册 · 4补充申请 · 10
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2600193 | 进口再注册 | 2026/08/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2600192 | 进口再注册 | 2026/08/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2500616 | 补充申请 | 2025/11/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH;Catalent France Beinheim | CDE ↗ |
| JYHB2500615 | 补充申请 | 2025/11/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH;Catalent France Beinheim | CDE ↗ |
| JYHB2400549 | 补充申请 | 2024/10/15 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400548 | 补充申请 | 2024/10/15 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400482 | 补充申请 | 2024/09/04 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2400481 | 补充申请 | 2024/09/04 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2200573 | 补充申请 | 2022/10/25 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2200572 | 补充申请 | 2022/10/25 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2100750 | 进口再注册 | 2021/12/31 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHZ2100749 | 进口再注册 | 2021/12/31 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2100109 | 补充申请 | 2021/01/30 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| JYHB2100108 | 补充申请 | 2021/01/30 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
马来酸阿法替尼片 24 件 · 最近受理 2026/08/05
补充申请 · 14进口再注册 · 10
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2600436 | 补充申请 | 2026/08/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600435 | 补充申请 | 2026/08/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2500255 | 进口再注册 | 2025/11/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500254 | 进口再注册 | 2025/11/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500253 | 进口再注册 | 2025/11/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500252 | 进口再注册 | 2025/11/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500473 | 补充申请 | 2025/09/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2500472 | 补充申请 | 2025/09/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200630 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200629 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200628 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200627 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200626 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200625 | 补充申请 | 2022/11/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200098 | 补充申请 | 2022/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200097 | 补充申请 | 2022/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200096 | 补充申请 | 2022/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200095 | 补充申请 | 2022/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2100505 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100504 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100503 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100502 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100501 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100500 | 进口再注册 | 2021/03/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
噻托溴铵吸入粉雾剂 9 件 · 最近受理 2026/07/02
来源未列 · 1补充申请 · 4进口再注册 · 4
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JTH2600126 | 来源未列 | 2026/07/02 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharmaceuticals Inc.;传思生物科技（上海）有限公司 | CDE ↗ |
| JYHB2600037 | 补充申请 | 2026/01/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600036 | 补充申请 | 2026/01/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2300455 | 进口再注册 | 2023/12/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300454 | 进口再注册 | 2023/12/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300422 | 进口再注册 | 2023/11/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300421 | 进口再注册 | 2023/11/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2101450 | 补充申请 | 2021/09/29 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101449 | 补充申请 | 2021/09/29 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
噻托溴铵奥达特罗吸入喷雾剂 3 件 · 最近受理 2026/06/17
补充申请 · 2进口再注册 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2600333 | 补充申请 | 2026/06/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2500306 | 补充申请 | 2025/06/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
| JYHZ2200292 | 进口再注册 | 2022/10/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
那米司特片 13 件 · 最近受理 2026/06/16
进口 · 11补充申请 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2600221 | 进口 | 2026/06/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600220 | 进口 | 2026/06/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2600221 | 补充申请 | 2026/04/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2600220 | 补充申请 | 2026/04/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2600116 | 进口 | 2026/04/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600115 | 进口 | 2026/04/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600090 | 进口 | 2026/03/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600089 | 进口 | 2026/03/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2600088 | 进口 | 2026/03/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500058 | 进口 | 2025/05/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500057 | 进口 | 2025/05/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500030 | 进口 | 2025/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2500029 | 进口 | 2025/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
注射用替奈普酶 5 件 · 最近受理 2026/06/10
补充申请 · 2进口 · 3
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYSB2600151 | 补充申请 | 2026/06/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JXSL2600112 | 进口 | 2026/05/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2500155 | 进口 | 2025/08/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2400001 | 进口 | 2024/01/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2200126 | 补充申请 | 2022/10/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
替米沙坦片 12 件 · 最近受理 2026/04/28
进口再注册 · 8补充申请 · 4
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2600106 | 进口再注册 | 2026/04/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Hellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600105 | 进口再注册 | 2026/04/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Hellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600104 | 进口再注册 | 2026/04/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Hellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600103 | 进口再注册 | 2026/04/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Hellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500220 | 补充申请 | 2025/04/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHB2500219 | 补充申请 | 2025/04/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHB2300703 | 补充申请 | 2023/12/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHB2300702 | 补充申请 | 2023/12/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHZ2100626 | 进口再注册 | 2021/09/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100625 | 进口再注册 | 2021/09/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100624 | 进口再注册 | 2021/09/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas A.E. | CDE ↗ |
| JYHZ2100623 | 进口再注册 | 2021/09/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ellas A.E. | CDE ↗ |
恩格列净片 31 件 · 最近受理 2026/04/01
进口再注册 · 7补充申请 · 20进口 · 4
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2600076 | 进口再注册 | 2026/04/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2600075 | 进口再注册 | 2026/04/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2500684 | 补充申请 | 2025/12/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2500683 | 补充申请 | 2025/12/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400612 | 补充申请 | 2024/11/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400611 | 补充申请 | 2024/11/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400610 | 补充申请 | 2024/11/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400609 | 补充申请 | 2024/11/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd | CDE ↗ |
| JYHB2400608 | 补充申请 | 2024/11/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2300717 | 补充申请 | 2023/12/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300716 | 补充申请 | 2023/12/14 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300083 | 补充申请 | 2023/02/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2300082 | 补充申请 | 2023/02/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHS2300001 | 进口 | 2023/01/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHS2200071 | 进口 | 2022/08/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co.，Ltd. | CDE ↗ |
| JXHS2200070 | 进口 | 2022/08/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co.，Ltd. | CDE ↗ |
| JYHB2200337 | 补充申请 | 2022/07/02 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200336 | 补充申请 | 2022/07/02 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2200210 | 补充申请 | 2022/04/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200214 | 补充申请 | 2022/04/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200213 | 补充申请 | 2022/04/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200212 | 补充申请 | 2022/04/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2200211 | 补充申请 | 2022/04/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JXHS2101074 | 进口 | 2021/11/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100609 | 进口再注册 | 2021/08/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100608 | 进口再注册 | 2021/08/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100607 | 进口再注册 | 2021/08/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100606 | 进口再注册 | 2021/08/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100605 | 进口再注册 | 2021/08/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2101032 | 补充申请 | 2021/06/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2101031 | 补充申请 | 2021/06/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
达比加群酯胶囊 14 件 · 最近受理 2026/03/10
补充申请 · 6进口再注册 · 8
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2600154 | 补充申请 | 2026/03/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYHB2600153 | 补充申请 | 2026/03/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYHZ2500229 | 进口再注册 | 2025/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500228 | 进口再注册 | 2025/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500227 | 进口再注册 | 2025/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2500226 | 进口再注册 | 2025/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2101612 | 补充申请 | 2021/12/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101611 | 补充申请 | 2021/12/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101610 | 补充申请 | 2021/12/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101609 | 补充申请 | 2021/12/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2100516 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100515 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100514 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2100513 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
利格列汀片 10 件 · 最近受理 2026/02/26
进口再注册 · 4补充申请 · 6
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2600047 | 进口再注册 | 2026/02/26 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2600046 | 进口再注册 | 2026/02/26 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2500095 | 补充申请 | 2025/02/27 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc. | CDE ↗ |
| JYHB2400311 | 补充申请 | 2024/06/21 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2400310 | 补充申请 | 2024/06/21 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim Seiyaku Co. Ltd. | CDE ↗ |
| JYHB2300302 | 补充申请 | 2023/05/23 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc. | CDE ↗ |
| JYHB2300301 | 补充申请 | 2023/05/23 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc. | CDE ↗ |
| JYHZ2100571 | 进口再注册 | 2021/07/06 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100570 | 进口再注册 | 2021/07/06 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2100110 | 补充申请 | 2021/02/03 | Boehringer Ingelheim International GmbH;West-Ward Columbus Inc. | CDE ↗ |
宗艾替尼片 3 件 · 最近受理 2026/02/06
进口 · 3
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2600032 | 进口 | 2026/02/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2600008 | 进口 | 2026/01/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHS2500124 | 进口 | 2025/10/31 | Boehringer Ingelheim International GmbH;Hovione Farmaciencia S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
BI3000202片 2 件 · 最近受理 2026/01/20
进口 · 2
BI764198片 2 件 · 最近受理 2026/01/16
进口 · 2
利格列汀二甲双胍片(II) 6 件 · 最近受理 2026/01/14
进口再注册 · 4补充申请 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2600003 | 进口再注册 | 2026/01/14 | Boehringer Ingelheim International GmbH;Dragenopharm Apotheker Püschl GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHZ2600002 | 进口再注册 | 2026/01/14 | Boehringer Ingelheim International GmbH;Dragenopharm Apotheker Püschl GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JYHB2500137 | 补充申请 | 2025/03/11 | Boehringer Ingelheim International GmbH;Dragenopharm Apotheker Püschl GmbH | CDE ↗ |
| JYHZ2100518 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2100517 | 进口再注册 | 2021/04/16 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2100070 | 补充申请 | 2021/01/19 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
BI1291583片 3 件 · 最近受理 2026/01/06
补充申请 · 2进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHB2600002 | 补充申请 | 2026/01/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500134 | 补充申请 | 2025/09/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2500035 | 进口 | 2025/03/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI764532输注用浓缩粉末 3 件 · 最近受理 2025/12/04
进口 · 2补充申请 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSL2500236 | 进口 | 2025/12/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2400069 | 补充申请 | 2024/06/05 | Boehringer Ingelheim International GmbH;Vetter Pharma-Fertigung GmbH & Co. KG | CDE ↗ |
| JXSL2300096 | 进口 | 2023/05/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
噻托溴铵吸入喷雾剂 5 件 · 最近受理 2025/11/13
补充申请 · 3进口再注册 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2500619 | 补充申请 | 2025/11/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2500019 | 进口再注册 | 2025/02/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2500018 | 进口再注册 | 2025/02/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2400633 | 补充申请 | 2024/12/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
| JYHB2400632 | 补充申请 | 2024/12/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
佩索利单抗注射液(皮下注射) 5 件 · 最近受理 2025/09/29
补充申请 · 3进口 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYSB2500238 | 补充申请 | 2025/09/29 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYSB2500043 | 补充申请 | 2025/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2400028 | 补充申请 | 2024/03/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400021 | 进口 | 2024/01/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSS2300039 | 进口 | 2023/05/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI1810631片 24 件 · 最近受理 2025/09/04
进口 · 7补充申请 · 17
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2500256 | 进口 | 2025/09/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2500065 | 补充申请 | 2025/05/13 | Boehringer Ingelheim International GmbH;Hovione FarmaCiencia SA;Seran BioScience LLC | CDE ↗ |
| JXHB2500046 | 补充申请 | 2025/04/14 | Boehringer Ingelheim International GmbH;Hovione FarmaCiencia SA;Seran BioScience LLC | CDE ↗ |
| JXHB2500036 | 补充申请 | 2025/04/08 | Boehringer Ingelheim International GmbH;Hovione FarmaCiencia SA;Seran BioScience LLC | CDE ↗ |
| JXHB2500004 | 补充申请 | 2025/02/08 | Boehringer Ingelheim International GmbH;Hovione FarmaCiencia SA | CDE ↗ |
| JXHL2400099 | 进口 | 2024/05/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2400030 | 进口 | 2024/02/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2300279 | 进口 | 2023/11/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHB2300162 | 补充申请 | 2023/10/14 | Boehringer Ingelheim International GmbH;Seran BioScience LLC;Hovione FarmaCiencia SA | CDE ↗ |
| JXHB2300161 | 补充申请 | 2023/10/14 | Boehringer Ingelheim International GmbH;Seran BioScience LLC | CDE ↗ |
| JXHB2300112 | 补充申请 | 2023/07/03 | Boehringer Ingelheim International GmbH;Seran BioScience LLC;Hovione FarmaCiencia SA | CDE ↗ |
| JXHB2300111 | 补充申请 | 2023/06/28 | Boehringer Ingelheim International GmbH;Seran BioScience LLC | CDE ↗ |
| JXHB2300110 | 补充申请 | 2023/06/28 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2300109 | 补充申请 | 2023/06/28 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2300108 | 补充申请 | 2023/06/28 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2300107 | 补充申请 | 2023/06/28 | Boehringer Ingelheim International GmbH;Seran BioScience LLC | CDE ↗ |
| JXHB2200136 | 补充申请 | 2022/09/10 | Boehringer Ingelheim International GmbH;Serán BioScience LLC | CDE ↗ |
| JXHB2200135 | 补充申请 | 2022/09/10 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2200134 | 补充申请 | 2022/09/10 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2200133 | 补充申请 | 2022/09/10 | Boehringer Ingelheim International GmbH;CoreRX Inc. | CDE ↗ |
| JXHB2200132 | 补充申请 | 2022/09/10 | Boehringer Ingelheim International GmbH;Serán BioScience LLC | CDE ↗ |
| JXHL2101108 | 进口 | 2021/06/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101107 | 进口 | 2021/06/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101106 | 进口 | 2021/06/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI907828片 12 件 · 最近受理 2025/06/17
进口 · 9补充申请 · 3
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2500147 | 进口 | 2025/06/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500146 | 进口 | 2025/06/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500145 | 进口 | 2025/06/17 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300153 | 进口 | 2023/06/30 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300152 | 进口 | 2023/06/30 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300151 | 进口 | 2023/06/30 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2300013 | 补充申请 | 2023/01/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2300012 | 补充申请 | 2023/01/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2300011 | 补充申请 | 2023/01/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHL2200139 | 进口 | 2022/06/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200138 | 进口 | 2022/06/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200137 | 进口 | 2022/06/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI690517片 7 件 · 最近受理 2025/06/11
进口 · 7
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHL2500132 | 进口 | 2025/06/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500073 | 进口 | 2025/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2500072 | 进口 | 2025/04/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400106 | 进口 | 2024/05/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400105 | 进口 | 2024/05/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101237 | 进口 | 2021/11/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101236 | 进口 | 2021/11/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI765049输注用粉末 2 件 · 最近受理 2025/05/16
补充申请 · 1进口 · 1
BI1015550片 14 件 · 最近受理 2025/05/01
补充申请 · 6进口 · 8
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHB2500054 | 补充申请 | 2025/05/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500053 | 补充申请 | 2025/05/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500015 | 补充申请 | 2025/03/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2500014 | 补充申请 | 2025/03/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2400210 | 进口 | 2024/08/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2400209 | 进口 | 2024/08/28 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300264 | 进口 | 2023/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300263 | 进口 | 2023/10/21 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2300079 | 补充申请 | 2023/05/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2300078 | 补充申请 | 2023/05/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2200219 | 进口 | 2022/08/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200218 | 进口 | 2022/08/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200217 | 进口 | 2022/07/26 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200216 | 进口 | 2022/07/26 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI1815368片 2 件 · 最近受理 2025/04/09
进口 · 2
佩索利单抗注射液 8 件 · 最近受理 2025/02/25
补充申请 · 2进口 · 6
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYSB2500042 | 补充申请 | 2025/02/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400145 | 进口 | 2024/08/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2400029 | 补充申请 | 2024/03/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2400020 | 进口 | 2024/01/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300042 | 进口 | 2023/02/24 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300041 | 进口 | 2023/02/24 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300022 | 进口 | 2023/01/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSL2300021 | 进口 | 2023/01/12 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
依达赛珠单抗注射液 4 件 · 最近受理 2025/02/18
补充申请 · 3进口再注册 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYSB2500040 | 补充申请 | 2025/02/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYSZ2200038 | 进口再注册 | 2022/08/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYSB2101218 | 补充申请 | 2021/12/31 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| JYSB2101110 | 补充申请 | 2021/08/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
盐酸普拉克索片 14 件 · 最近受理 2025/01/27
补充申请 · 10进口再注册 · 4
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2500053 | 补充申请 | 2025/01/27 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500052 | 补充申请 | 2025/01/27 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500051 | 补充申请 | 2025/01/27 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2500050 | 补充申请 | 2025/01/27 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400398 | 补充申请 | 2024/07/26 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400397 | 补充申请 | 2024/07/26 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400396 | 补充申请 | 2024/07/26 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400156 | 补充申请 | 2024/04/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400155 | 补充申请 | 2024/04/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2400154 | 补充申请 | 2024/04/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHZ2400007 | 进口再注册 | 2024/01/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400006 | 进口再注册 | 2024/01/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400005 | 进口再注册 | 2024/01/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2400004 | 进口再注册 | 2024/01/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
宗格替尼片 1 件 · 最近受理 2025/01/15
进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHS2500002 | 进口 | 2025/01/15 | Boehringer Ingelheim International GmbH;Hovione Farmaciencia S.A.;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
替米沙坦氢氯噻嗪片 5 件 · 最近受理 2025/01/08
补充申请 · 3进口再注册 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2500006 | 补充申请 | 2025/01/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHB2400676 | 补充申请 | 2024/12/25 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
| JYHZ2300357 | 进口再注册 | 2023/09/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300356 | 进口再注册 | 2023/09/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A.;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200591 | 补充申请 | 2022/11/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Ηellas Single Member S.A. | CDE ↗ |
BI765179注射用粉末 1 件 · 最近受理 2024/09/04
进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSL2400161 | 进口 | 2024/09/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI1839100片 2 件 · 最近受理 2024/07/12
进口 · 2
盐酸普拉克索缓释片 13 件 · 最近受理 2024/07/04
补充申请 · 8进口再注册 · 5
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2400340 | 补充申请 | 2024/07/04 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400339 | 补充申请 | 2024/07/04 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2400337 | 补充申请 | 2024/07/04 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHZ2300472 | 进口再注册 | 2023/12/29 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300471 | 进口再注册 | 2023/12/29 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300470 | 进口再注册 | 2023/12/29 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300469 | 进口再注册 | 2023/12/29 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300468 | 进口再注册 | 2023/12/29 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200186 | 补充申请 | 2022/04/08 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200185 | 补充申请 | 2022/04/08 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200184 | 补充申请 | 2022/04/08 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200183 | 补充申请 | 2022/04/08 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
| JYHB2200182 | 补充申请 | 2022/04/08 | Boehringer Ingelheim International GmbH;Rottendorf Pharma GmbH | CDE ↗ |
BI1819479片 2 件 · 最近受理 2024/04/11
进口 · 2
BI685509片 24 件 · 最近受理 2024/01/04
补充申请 · 9进口 · 15
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHB2400006 | 补充申请 | 2024/01/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2400005 | 补充申请 | 2024/01/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2400004 | 补充申请 | 2024/01/04 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2300195 | 进口 | 2023/08/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300194 | 进口 | 2023/08/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2300193 | 进口 | 2023/08/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2200169 | 补充申请 | 2022/11/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2200168 | 补充申请 | 2022/11/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2200167 | 补充申请 | 2022/11/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2200207 | 进口 | 2022/07/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200206 | 进口 | 2022/07/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200205 | 进口 | 2022/07/20 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200074 | 进口 | 2022/04/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200073 | 进口 | 2022/04/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200072 | 进口 | 2022/04/01 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHB2101119 | 补充申请 | 2021/12/23 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2101118 | 补充申请 | 2021/12/23 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2101117 | 补充申请 | 2021/12/23 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHL2101224 | 进口 | 2021/10/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| JXHL2101223 | 进口 | 2021/10/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2101222 | 进口 | 2021/10/27 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2100020 | 进口 | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2100019 | 进口 | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
| JXHL2100018 | 进口 | 2021/01/19 | Boehringer Ingelheim International GmbH | CDE ↗ |
BI1569912片 2 件 · 最近受理 2023/12/26
进口 · 2
替米沙坦氨氯地平片 3 件 · 最近受理 2023/11/25
补充申请 · 2进口再注册 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHB2300686 | 补充申请 | 2023/11/25 | Boehringer Ingelheim International GmbH;Cipla Ltd. Goa | CDE ↗ |
| JYHZ2200004 | 进口再注册 | 2022/01/07 | Boehringer Ingelheim International GmbH;Cipla Ltd. Goa;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2101485 | 补充申请 | 2021/10/26 | Boehringer Ingelheim International GmbH;Cipla Ltd. Goa | CDE ↗ |
BI764198胶囊 6 件 · 最近受理 2023/10/11
补充申请 · 3进口 · 3
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHB2300160 | 补充申请 | 2023/10/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2300159 | 补充申请 | 2023/10/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHB2300158 | 补充申请 | 2023/10/11 | Boehringer Ingelheim International GmbH;Almac Pharma Services Limited | CDE ↗ |
| JXHL2200161 | 进口 | 2022/06/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200160 | 进口 | 2022/06/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2200159 | 进口 | 2022/06/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
二甲双胍恩格列净片(III) 3 件 · 最近受理 2023/07/15
进口再注册 · 2补充申请 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2300306 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300305 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200425 | 补充申请 | 2022/08/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
二甲双胍恩格列净片(IV) 3 件 · 最近受理 2023/07/15
进口再注册 · 2补充申请 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2300308 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHZ2300307 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200426 | 补充申请 | 2022/08/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
二甲双胍恩格列净片(V) 3 件 · 最近受理 2023/07/15
进口再注册 · 1补充申请 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2300309 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200427 | 补充申请 | 2022/08/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101089 | 补充申请 | 2021/05/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
二甲双胍恩格列净片(VI) 3 件 · 最近受理 2023/07/15
进口再注册 · 1补充申请 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JYHZ2300310 | 进口再注册 | 2023/07/15 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JYHB2200428 | 补充申请 | 2022/08/08 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JYHB2101090 | 补充申请 | 2021/05/11 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
BI425809片 4 件 · 最近受理 2023/02/22
补充申请 · 2进口 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXHB2300044 | 补充申请 | 2023/02/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHB2300043 | 补充申请 | 2023/02/22 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXHL2101086 | 进口 | 2021/06/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXHL2100015 | 进口 | 2021/01/16 | Boehringer Ingelheim International GmbH | CDE ↗ |
BI655130注射液 4 件 · 最近受理 2022/10/18
补充申请 · 2进口 · 2
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSB2200130 | 补充申请 | 2022/10/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101098 | 进口 | 2021/08/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| JXSB2101037 | 补充申请 | 2021/07/24 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101006 | 进口 | 2021/04/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI905711输注用粉末 3 件 · 最近受理 2022/07/18
补充申请 · 2进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSB2200095 | 补充申请 | 2022/07/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2200070 | 补充申请 | 2022/06/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSL2101085 | 进口 | 2021/08/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
司柏索利单抗注射液 1 件 · 最近受理 2021/11/18
进口 · 1
| 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|
| JXSS2101030 | 进口 | 2021/11/18 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
BI1701963片 2 件 · 最近受理 2021/08/09
进口 · 2
近 90 天变化
2026/08/14 至 2026/11/11 共 14 条事件。CDE 来源截至 2026/11/11 06:42；NMPA 来源截至 2026/11/10 18:31。
该来源最近成功更新于 2026/11/10 18:31，当前覆盖可能不完整。
近 90 天，按事实日期倒序。批准证明、试验登记、补充申请、通知件与在审变化分别标记。 批准日、受理日、试验首次公示日或完整快照观察日为对应事实日期；公告日期与本站发现日期另列。历史补录不计为本期新增。退出记录只展示当前已不在审、且可定位完整快照日期的记录，不代表完整历史轨迹。
新受理 14 件
- 2026/11/09新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/10/13新受理
- 2026/09/23新受理
- 2026/09/23新受理
- 2026/09/23新受理
- 2026/09/23新受理
- 2026/09/23新受理
- 2026/09/03新受理
在审
本企业作为第一申请人、目前仍列于 CDE 在审名单的 23 个受理号；来源截至 2026/11/11 06:42。
| 品种 | 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|---|
| BI3822971注射液 | JXSL2600307 | 进口 | 2026/11/09 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600448 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600447 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600446 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600445 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600444 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600443 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI456906注射液 | JXHL2600442 | 进口 | 2026/10/13 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI3034701注射液 | JXHL2600416 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI3034701注射液 | JXHL2600415 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI3034701注射液 | JXHL2600414 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI3034701注射液 | JXHL2600413 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| BI3034701注射液 | JXHL2600412 | 进口 | 2026/09/23 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd | CDE ↗ |
| verducatib片 | JXHL2600392 | 进口 | 2026/09/03 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co. Ltd. | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | JYHZ2600193 | 进口再注册 | 2026/08/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | JYHZ2600192 | 进口再注册 | 2026/08/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH | CDE ↗ |
| 马来酸阿法替尼片 | JYHB2600436 | 补充申请 | 2026/08/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| 马来酸阿法替尼片 | JYHB2600435 | 补充申请 | 2026/08/05 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| 达比加群酯胶囊 | JYHB2600154 | 补充申请 | 2026/03/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| 达比加群酯胶囊 | JYHB2600153 | 补充申请 | 2026/03/10 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co.KG | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | JYHB2500616 | 补充申请 | 2025/11/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH;Catalent France Beinheim | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | JYHB2500615 | 补充申请 | 2025/11/12 | Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH;Catalent France Beinheim | CDE ↗ |
| 噻托溴铵奥达特罗吸入喷雾剂 | JYHB2500306 | 补充申请 | 2025/06/06 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim Espa？a S.A. | CDE ↗ |
目录集持有记录
已载入目录集中，持有人名称与本企业来源名称匹配的有效记录 18 条；来源截至 2026/11/11 06:38。不计仅作为生产企业出现的记录。
| 品种 | 上市许可持有人 | 生产企业 | 批准文号 | 批准日期 | 收录类别（原文） | 查看出处 |
|---|---|---|---|---|---|---|
| 奥达特罗吸入喷雾剂 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20180058 | 2018/10/15 | 进口原研药品 | CDE ↗ |
| 噻托溴铵奥达特罗吸入喷雾剂 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20180037 | 2018/07/18 | 进口原研药品 | CDE ↗ |
| 恩格列净片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170351 | 2017/09/20 | 进口原研药品 | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | Boehringer Ingelheim International GmbH | Catalent Germany Eberbach GmbH | H20170355 | 2017/09/20 | 进口原研药品 | CDE ↗ |
| 乙磺酸尼达尼布软胶囊 | Boehringer Ingelheim International GmbH | Catalent Germany Eberbach GmbH | H20170354 | 2017/09/20 | 进口原研药品 | CDE ↗ |
| 马来酸阿法替尼片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170066;H20170067 | 2017/02/21 | 进口原研药品 | CDE ↗ |
| 马来酸阿法替尼片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20170068;H20170069 | 2017/02/21 | 进口原研药品 | CDE ↗ |
| 盐酸普拉克索缓释片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140583;H20140584 | 2014/08/01 | 进口原研药品 | CDE ↗ |
| 盐酸普拉克索缓释片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140579;H20140580 | 2014/08/01 | 进口原研药品 | CDE ↗ |
| 利格列汀片 | Boehringer Ingelheim International GmbH | West-Ward Columbus Inc. | H20171166;H20171167;H20171168;H20171169 | 2013/03/26 | 进口原研药品 | CDE ↗ |
| 达比加群酯胶囊 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20170148; H20170135 | 2013/02/22 | 进口原研药品 | CDE ↗ |
| 达比加群酯胶囊 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20170149; H20170136 | 2013/02/22 | 进口原研药品 | CDE ↗ |
| 替米沙坦氢氯噻嗪片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmBH& Co. KG | H20171206;H20171207;H20171208 | 2008/12/19 | 进口原研药品 | CDE ↗ |
| 盐酸普拉克索片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140917 | 2005/12/30 | 进口原研药品 | CDE ↗ |
| 盐酸普拉克索片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharm GmbH & Co. KG | H20140918 | 2005/12/30 | 进口原研药品 | CDE ↗ |
| 噻托溴铵粉吸入剂 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co. KG | H20140933;H20140954 | 2005/05/10 | 进口原研药品 | CDE ↗ |
| 替米沙坦片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20150134; H20150135 | 2001/09/06 | 进口原研药品 | CDE ↗ |
| 替米沙坦片 | Boehringer Ingelheim International GmbH | Boehringer Ingelheim Pharma GmbH & Co.KG | H20150137; H20150138 | 2001/09/06 | 进口原研药品 | CDE ↗ |
仅按来源中的持有人名称列出有效目录集记录，不将生产企业身份计作持有记录。目录集仅覆盖部分化学药品；收录类别不代表完整市场范围或资质结论。
原料药登记记录
已载入原料药登记中，首位登记企业名称与本企业来源名称匹配的有效记录 0 条；来源截至 2026/11/11 06:40。
| 名称 | 企业／申请人 | 登记号 | 状态 | 来源更新日期 | 查看出处 |
|---|---|---|---|---|---|
| 在本站当前已载入的该来源记录中未检出匹配项；覆盖时间见下方说明。 | |||||
仅列已载入、有效且未列为注销的原料药登记记录。A/I 为来源登记状态；登记条数按登记号列示，不能据此推定产能或供应情况。登记平台不标识关联制剂。
联合申请记录
本企业出现在第一申请人之后的 18 件受理记录，单独列示，不计入第一申请人的品种或受理件数；来源截至 2026/11/11 06:42。
| 品种 | 受理号 | 申请类型 | 受理日期 | 企业／申请人 | 查看出处 |
|---|---|---|---|---|---|
| 噻托溴铵一水合物 | JTH2600177 | 来源未列 | 2026/08/24 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 异丙托溴铵一水合物 | JTH2600170 | 来源未列 | 2026/08/12 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI456906注射液 | JTH2600060 | 来源未列 | 2026/03/21 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 噻托溴铵一水合物 | JTH2400188 | 来源未列 | 2024/11/08 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 替米沙坦片 | JTH2400169 | 来源未列 | 2024/10/08 | Boehringer Ingelheim Ηellas Single Member S.A.;Boehringer Ingelheim International GmbH;天津市康瑞药业有限公司 | CDE ↗ |
| BI425809片 | JTH2400085 | 来源未列 | 2024/06/18 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI1015550(Nerandomilast)片 | JTH2400072 | 来源未列 | 2024/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI1015550(Nerandomilast)片 | JTH2400071 | 来源未列 | 2024/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI1810631片 | JTH2400063 | 来源未列 | 2024/05/08 | Hovione FarmaCiencia SA;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI907828片 | JTH2300212 | 来源未列 | 2023/09/06 | Almac Pharma Services Limited;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI907828片 | JTH2300211 | 来源未列 | 2023/09/06 | Almac Pharma Services Limited;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| BI907828片 | JTH2300210 | 来源未列 | 2023/09/06 | Almac Pharma Services Limited;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 替米沙坦片 | JTH2300198 | 来源未列 | 2023/08/21 | Boehringer Ingelheim Ηellas Single Member S.A.;Boehringer Ingelheim International GmbH;天津市康瑞药业有限公司 | CDE ↗ |
| 噻托溴铵一水合物 | JTH2300157 | 来源未列 | 2023/06/27 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 佩索利单抗注射液(预填充) | JTS2300001 | 来源未列 | 2023/01/11 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 异丙托溴铵一水合物 | JTH2100722 | 来源未列 | 2021/12/16 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| 噻托溴铵一水合物 | JTH2100693 | 来源未列 | 2021/11/22 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
| Spesolimab(BI655130)注射液 | JTS2100501 | 来源未列 | 2021/05/17 | Boehringer Ingelheim Pharma GmbH & Co. KG;Boehringer Ingelheim International GmbH;勃林格殷格翰(中国)投资有限公司 | CDE ↗ |
数据覆盖到什么时候？
- CDE 受理与在审
- 最近成功时间: 2026/11/11 06:42
- 化学药品目录集
- 最近成功时间: 2026/11/11 06:38
- 原料药登记整表
- 最近成功时间: 2026/11/11 06:40
- NMPA 药品送达
- 最近成功时间: 2026/11/10 18:31 · 本次覆盖可能不完整
目录首屏公告日期范围：— 至 —；待处理页面 0 个。只覆盖已载入公告，并非完整历史批文库。
按来源记录的企业名称原文列出，未与关联企业合并。
仅汇总本站已载入记录，不新增查询或采集。名称不合并母子公司、曾用名或别名；不同来源的条数不相加。无记录不代表没有申报或登记。来源不完整、更新未成功或超出覆盖范围时均须结合原始记录核对。
批准日、受理日、试验首次公示日或完整快照观察日为对应事实日期；公告日期与本站发现日期另列。历史补录不计为本期新增。退出记录只展示当前已不在审、且可定位完整快照日期的记录，不代表完整历史轨迹。